EVER HEALTH BIO MEDICAL INTERNATIONAL CO., LTD.
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
Immune Cell Storage, CIK Cell Storage, Adipose-Derived Mesenchymal Stem Cell Storage, Umbilical Cord Mesenchymal Stem Cell Storage
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2015
Unified Business No.
54904932
Status
Active
Number of Employees
0
Total Paid-in
Capital
60,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
The human body is composed of organs and cells, but these cells, which total up to 60 trillion, face two major problems:
First, they undergo apoptosis at a rate of 1% to 2% per day. Because cell repair and the supply of new cells are often insufficient, human aging and aging-related diseases occur as a result. Therefore, the powerful effects of stem cells and exosomes on aging-related diseases and anti-aging have become the focus of global attention in regenerative medicine today.
Second, autoimmune capacity, which is primarily driven by immune cells, peaks at the age of 25 and then declines at a rate of approximately 1% per year, causing the incidence of diseases such as cancer to increase with age. Since traditional surgeries, radiotherapy, and chemotherapy have significant side effects and limitations, immune cell therapy is highly anticipated to become a beacon of hope for cancer patients. Whether it is stem cells, exosomes, or immune cells, they may all be the key to improving your health or even saving your life in the future.
The business focus of EVER HEALTH BIO MEDICAL INTERNATIONAL CO., LTD. is on the storage, research, and application of various types of cells, including stem cells, exosomes, and immune cells, as well as assisting clients in consulting with medical institutions that comply with the standards of the Ministry of Health and Welfare's Regulations Governing the Application of Specific Medical Technology, thoughtfully considering clients' health from multiple perspectives.
(The content above was translated by AI.)
First, they undergo apoptosis at a rate of 1% to 2% per day. Because cell repair and the supply of new cells are often insufficient, human aging and aging-related diseases occur as a result. Therefore, the powerful effects of stem cells and exosomes on aging-related diseases and anti-aging have become the focus of global attention in regenerative medicine today.
Second, autoimmune capacity, which is primarily driven by immune cells, peaks at the age of 25 and then declines at a rate of approximately 1% per year, causing the incidence of diseases such as cancer to increase with age. Since traditional surgeries, radiotherapy, and chemotherapy have significant side effects and limitations, immune cell therapy is highly anticipated to become a beacon of hope for cancer patients. Whether it is stem cells, exosomes, or immune cells, they may all be the key to improving your health or even saving your life in the future.
The business focus of EVER HEALTH BIO MEDICAL INTERNATIONAL CO., LTD. is on the storage, research, and application of various types of cells, including stem cells, exosomes, and immune cells, as well as assisting clients in consulting with medical institutions that comply with the standards of the Ministry of Health and Welfare's Regulations Governing the Application of Specific Medical Technology, thoughtfully considering clients' health from multiple perspectives.
(The content above was translated by AI.)
